CORD-19:4ca5d854d3f99440b507fd7dfae73c8ad6fc45d5 / 204971-205144 JSONTXT

{"target":"https://pubannotation.org/docs/sourcedb/CORD-19/sourceid/4ca5d854d3f99440b507fd7dfae73c8ad6fc45d5","sourcedb":"CORD-19","sourceid":"4ca5d854d3f99440b507fd7dfae73c8ad6fc45d5","text":"Subsequently, in vitro generated human dendritic cells (DCs) were treated with recombinant ADI or mutADI (C424A) in absence and presence of Toll-like receptor (TLR) ligands.","tracks":[{"project":"CORD-19-Sentences","denotations":[{"id":"T60744","span":{"begin":0,"end":173},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"attributes":[{"subj":"T60744","pred":"source","obj":"CORD-19-Sentences"}]},{"project":"CORD-19_Custom_license_subset","denotations":[{"id":"T112","span":{"begin":0,"end":173},"obj":"Sentence"}],"attributes":[{"subj":"T112","pred":"source","obj":"CORD-19_Custom_license_subset"}]}],"config":{"attribute types":[{"pred":"source","value type":"selection","values":[{"id":"CORD-19-Sentences","color":"#e8ec93","default":true},{"id":"CORD-19_Custom_license_subset","color":"#d693ec"}]}]}}